¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"REC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • rectoromanoscope
    Á÷À屸ºÒ°áÀå°æ
  • rectoromanoscopy
    Á÷À屸ºÒ°áÀå°æ°Ë»ç(¹ý)
  • rectorrhaphy
    Á÷ÀåºÀÇÕ(¼ú), °ðâÀÚºÀÇÕ(¼ú)
  • rectoscope
    Á÷Àå°æ
  • rectoscopy
    Á÷Àå°æ°Ë»ç(¹ý)
  • rectosigmoid
    Á÷À屸ºÒ°áÀå-, °ðâÀÚ±¸ºÒâÀÚ-
  • rectosigmoidectomy
    Á÷À屸ºÒ°áÀåÀýÁ¦(¼ú), °ðâÀÚ±¸ºÒâÀÚÀýÁ¦(¼ú)
  • rectosigmoidoscope
    Á÷À屸ºÒ°áÀå°æ
  • rectostenosis
    Á÷ÀåÇùÂø, °ðâÀÚÇùÂø
  • rectotome
    Á÷ÀåÀý°³µµ, °ðâÀÚÀý°³Ä®
  • rectotomy
    Á÷ÀåÀý°³(¼ú), °ðâÀÚÀý°³(¼ú)
  • rectourethral
    Á÷Àå¿äµµ-, °ðâÀÚ¿äµµ-
  • rectourethral fistula
    Á÷Àå¿äµµ·ç, °ðâÀÚ¿äµµ»û±æ
  • rectouterine
    Á÷ÀåÀÚ±Ã-, °ðâÀÚÀÚ±Ã-
  • rectouterine excavation
    ´õ±Û¶ó½ºÁÖ¸Ó´Ï, Á÷ÀåÀڱÿÀ¸ñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • rectifier
    Á¤·ù±â
  • rectifier tube
    Á¤·ù°ü
  • rectilinear
    Á÷¼±-
  • rectilinear propagation
    Á÷Áø
  • rectitis
    (¢¡proctitis) °ðâÀÚ¿°, Á÷Àå¿°
  • rectoabdominal
    °ðâÀÚ¹è-, Á÷À庹ºÎ-
  • rectocele
    °ðâÀÚÅ»ÃâÁõ, Á÷Àå·ù
  • rectococcygeal muscle
    °ðâÀÚ²¿¸®±Ù
  • rectococcypexy
    (¢¡proctococcypexy) °ðâÀÚ²¿¸®»À°íÁ¤¼ú, Á÷Àå¹Ì°ñ°íÁ¤¼ú
  • rectocolitis
    °ðâÀÚ°áÀå¿°, Á÷Àå°áÀå¿°
  • rectocystotomy
    (¢¡proctocystotomy) °ðâÀڹ汤Àý°³¼ú, Á÷À广±¤Àý°³¼ú
  • rectofistula
    °ðâÀÚ»û±æ, Á÷Àå»û±æ
  • rectogenital
    °ðâÀÚ¼º±â-
  • rectolabial
    °ðâÀÚÀ½¼ø-, Á÷ÀåÀ½¼ø-
  • rectolabial fistula
    °ðâÀÚÀ½¼ø»û±æ, Á÷ÀåÀ½¼ø·ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • recombination correction
    Àç°áÇÕ±³Á¤
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • recombination frequency
    ÀçÁ¶ÇÕºóµµ
  • recombination rate
    Àç°áÇÕ·ü(¡­ëÒ).
  • recombination value
    Àç°áÇÕ°ª.
  • recombination, gene
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • recombination, high frequency (Hfr)
    °íºóµµÀçÁ¶ÇÕ
  • recombination, illegitimate
    ºñÁ¤±ÔÀçÁ¶ÇÕ
  • recombinational repair
    ÀçÁ¶ÇÕ(¼º) DNAº¹±¸
  • recommended dietary allowance
    À½½Ä¹°±ÇÀå·®.
  • recommended dietary allowance
    ¿µ¾ç±ÇÀå·®(ç½å×ÏèíáåÖ).
  • recomposition
    ÀçÁ¶¼º(î¢ðãà÷), À籸¼º(î¢Ï°à÷).
  • recompression
    Àç°¡¾Ð(î¢Ê¥äâ).
  • recompression treatment
    Àç°¡¾Ð¿ä¹ý (¡­èþÛö).
  • recon
    ÀçÁ¶ÇÕ ´ÜÀ§À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • reciprocal beat
    »ó¹Ý¸Æ¹Ú.
  • reciprocal conduction
    »ó¹ÝÀüµµ.
  • reciprocal crossing
    »ó¹Ý±³¹è(ßÓÚãÎßÛÕ), ¿ª±³Àâ(æ½ÎßíÚ).
  • reciprocal difference
    ¿ªÂ÷ºÐ(æ½ó¬ÝÂ).
  • reciprocal hybrid
    »ó¹ÝÀâÁ¾(ßÓÚãíÚðú).
  • reciprocal inhibition
    »óÈ£¾ïÁ¦
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦(ßÓÚãåäð¤).
  • reciprocal inhibition psychotherapy
    »óÈ£Á¦ÁöÁ¤½ÅÄ¡·á.
  • reciprocal innervation
    »ó¹ÝÀû½Å°æÁö¹è
  • reciprocal innervation
    »ó¹Ý½Å°æÁö¹è(ßÓÚããêÌèò¨ÛÕ).
  • reciprocal proportion
    ¹Ýºñ·Ê(ËÑËÓËç).
  • reciprocal retention
    »ó¹ÝÁ¤Ã¼(ßÓÚãïÎôò).
  • reciprocal rhythm
    Àç±Í¸®µë
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â(èÙÜÖòè.JÐï).
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
receptors, nerve growth factor Cell surface receptors that bind nerve growth factor (ngf) and trigger intracellular changes influencing the behaviour of cells. Nerve growth factor receptors mediate the effects of nerve growth factor on the survival and growth of neurons.
(12 Dec 1998)
receptors, neurokinin-1 A class of cell surface receptors for tachykinins with a preference for substance p. Neurokinin-1 (nk-1) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.
(12 Dec 1998)
receptors, neurokinin-2 A class of cell surface receptors for tachykinins that prefers neurokinin a (nka, substance k, neurokinin alpha, neuromedin l), neuropeptide k (npk), or neuropeptide gamma over other tachykinins. Neurokinin-2 (nk-2) receptors have been cloned and are similar to other g-protein coupled receptors.
(12 Dec 1998)
receptors, neurokinin-3 A class of cell surface receptors for tachykinins that prefers neurokinin b (neurokinin beta, neuromedin k) over other tachykinins. Neurokinin-3 (nk-3) receptors have been cloned and are members of the g-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues.
(12 Dec 1998)
receptors, neuropeptide Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behaviour of cells. Many neuropeptides are also hormones outside of the nervous system.
(12 Dec 1998)
receptors, neuropeptide y Cell surface proteins that bind neuropeptide y with high affinity and trigger intracellular changes which influence the behaviour of cells.
(12 Dec 1998)
receptors, neurotensin Cell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behaviour of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery.
(12 Dec 1998)
receptors, neurotransmitter Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.
(12 Dec 1998)
receptors, nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for nicotine over muscarine. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, molecular biology, and biophysical properties of the channels.
(12 Dec 1998)
receptors, odourant Proteins, usually projecting from the cilia of olfactory receptor neurons, that specifically bind odourant molecules and trigger responses in the neurons. The large number of different odourant receptors appears to arise from several gene families or subfamilies rather than from DNA rearrangement.
(12 Dec 1998)
receptors, opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behaviour of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
(12 Dec 1998)
receptors, opioid, delta A class of opioid receptors recognised by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.
(12 Dec 1998)
receptors, opioid, kappa A class of opioid receptors recognised by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.
(12 Dec 1998)
receptors, opioid, mu A class of opioid receptors recognised by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
(12 Dec 1998)
receptors, oxytocin Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behaviour of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 11
  • Receptor, Macrophage Colony-Stimulating Factor - »õâ A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene (GENES, FMS). It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.
    Synonyms : CD115 Antigen, M-CSF Receptors, Macrophage Colony-Stimulating Factor Receptors, Receptors, CSF-1, Receptors, M-CSF, Receptors, Macrophage Colony-Stimulating Factor, Antigen, CD115, CSF-1 Receptors, Macrophage Colony Stimulating Factor Receptors, Receptor, CSF 1
  • Receptor, Melanocortin, Type 1 - »õâ A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and ADRENOCORTICOTROPIC HORMONE. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human.
    Synonyms : MC1 Receptor, Melanocortin-1 Receptor, Melanocyte Melanocortin Receptor, Receptor, Melanocortin-1, Melanocortin 1 Receptor, Melanocortin Receptor, Melanocyte, Receptor 1, Melanocortin, Receptor, MC1, Receptor, Melanocortin 1, Receptor, Melanocyte Melanocortin
  • Receptor, Melanocortin, Type 2 - »õâ A melanocortin receptor subtype found primarily in the ADRENAL CORTEX. It shows specificity for ADRENOCORTICOTROPIC HORMONE.
    Synonyms : MC2 Receptor, Melanocortin-2 Receptor, Receptor, Melanocortin-2, Melanocortin 2 Receptor, Receptor, MC2, Receptor, Melanocortin 2
  • Receptor, Melanocortin, Type 3 - »õâ A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH; GAMMA-MSH and ADRENOCORTICOTROPIC HORMONE.
    Synonyms : MC3 Receptor, Melanocortin-3 Receptor, Receptor, Melanocortin 3, Melanocortin 3 Receptor, Receptor, MC3, Receptor, Melanocortin-3
  • Receptor, Melanocortin, Type 4 - »õâ A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH and ADRENOCORTICOTROPIC HORMONE.
    Synonyms : MC4 Receptor, Melanocortin 4 Receptor, Melanocortin-4 Receptor, Receptor, Melanocortin-4, Receptor 4, Melanocortin, Receptor, MC4, Receptor, Melanocortin 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
recombinant Made through genetic engineering, which is also called gene splicing or recombinant DNA technology. By putting animal or plant genes into the genetic material of bacteria or yeast cells, these microorganisms can be turned into "factories" to make proteins for medical uses.
Ãâó: www.stjude.org/glossary
receiver operating characteristic curve one plotting sensitivity versus [1 - specificity (or false-positive error rate)] to help determine the best cutoff point or points for demarcating dimensional data in diagnostic tests for disease, optimizing the balance between sensitivity and specificity.
Ãâó: www.merckmedicus.com/pp/us/hcp/thcp_dorlands_conte...
recurrent Costs associated with the day-to-day operation of the MCS system. These include salaries, costs of maintenance of the capital assets, communications, travel, fuel and energy.
Ãâó: www.fao.org/DOCREP/005/Y3780E/y3780e04.htm
recombinant protein A protein whose amino acid sequence is encoded by a cloned gene.
Ãâó: www.fao.org/docrep/003/X3910E/X3910E21.htm
receptor A molecule that can accept the binding of a ligand.
Ãâó: www.fao.org/docrep/003/X3910E/X3910E21.htm
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • recitative
    ¼­Ã¢Á¶
  • recitative
    ¼­Ã¢;·¹Ä¡Å¸Æ¼º¸;=RECITATION;·¹Ä¡Å¸Å¸º¸ dzÀÇ;¼­¼ú(¼³È­)ÀÇ;¸®»çÀÌÆ²ÀÇ
  • recite
    ¾Ï¼ÛÇÏ´Ù
  • recite
    (ûÁß ¾Õ¿¡¼­)À¼´Ù;¾Ï¼ÛÇÏ´Ù;³¶¼Û(³¶µ¶)ÇÏ´Ù;À̾߱âÇÏ´Ù;¿­°ÅÇÏ´Ù;¹®¼­¿¡(»ç½ÇÀ»)ÀÚ¼¼È÷ ±â¼úÇÏ´Ù;(Àϰú¸¦)º¹Ã¢ÇÏ´Ù;(±³»çÀÇ)Áú¹®¿¡ ±¸µÎ·Î ´äÇÏ´Ù;´Ù½Ã ÀοëÇÏ´Ù
  • recited
    ¾Ï¼ÛÇÏ´Ù
  • reciter
    À¼´Â »ç¶÷;¾Ï¼Û(³¶¼Û)ÀÚ;¾Ï¼Û¿ë ¹®Àå ¸ðÀ½;º¹Ã¢ÀÚ
  • reciting note
    ³¶¼ÛÁ¶;³¶Ã¢À½
  • reck
    °³ÀÇÇÏ´Ù;¸¶À½À» ¾²´Ù;°ü°èÇÏ´Ù
  • reckless
    ¹«¸ðÇÑ; ¾Õ µÚ¸¦ Çì¾Æ¸®Áö ¾Ê´Â
  • reckless
    ¾ÕµÚ¸¦ °¡¸®Áö ¾Ê´Â;¹«¸ðÇÑ;°³ÀÇÄ¡ ¾Ê´Â;~ly ¹«¸ðÇϰÔ;°³ÀÇÄ¡ ¾Ê°í;~ness
  • recklessly
    ¹«¸ðÇϰÔ
  • recklessness
    ¹«°ü½É
  • reckon
    ¼¼´Ù
  • reckon
    (¼ö¸¦)¼¼´Ù;°è»êÇÏ´Ù;ÃѰèÇÏ´Ù;ÇÕ°è...ÀÌ µÇ´Ù;±â»êÇÏ´Ù;ÆÇ´Ü(ÆÇÁ¤)ÇÏ´Ù;Æò°¡ÇÏ´Ù;(...À»)...ÀÇ Çϳª(ÇÑ »ç¶÷)·Î º¸´Ù;¼À¿¡ ³Ö´Ù;°£ÁÖÇÏ´Ù;...À¸·Î Ä¡´Ù(»ý°¢ÇÏ´Ù);Áö¿ì´Ù;µé¸®´Ù;Å¿À¸·Î ÇÏ´Ù;µÚÁý¾î ¾º¿ì´Ù;ÁöºÒÇÏ´Ù;Á¤»ê(°á»ê)ÇÏ´Ù;ÆÇ´Ü(»ý°¢)ÇÏ´Ù;±â´ëÇÏ´Ù;½Å·ÚÇÏ´Ù;~er
  • reckoner
    °è»êÀÚ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 11
REC close at the end of a session
REC make a recess in
REC put into a recess
REC resembling an alcove
REC having a sunken area
REC the act of becoming more distant
REC the act of ceding back
REC a small concavity
REC the state of the economy declines
REC a hymn that is sung at the end of a service as the clergy and choir withdraw
REC of or relating to receding
REC a march to be played for processions
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 11
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á